Cargando…

Follistatin Like 5 (FSTL5) inhibits epithelial to mesenchymal transition in hepatocellular carcinoma

BACKGROUND: Epithelial to mesenchymal transition (EMT) is a key process in determining distant metastasis and intra-hepatic dissemination of hepatocellular carcinoma (HCC). Follistatin (FST) family members are considered to be an attractive therapeutic targets and prognostic indicators in cancers. A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Deng-Yong, Lei, Jia-Sheng, Sun, Wan-Liang, Wang, Dong-Dong, Lu, Zheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469996/ https://www.ncbi.nlm.nih.gov/pubmed/32740091 http://dx.doi.org/10.1097/CM9.0000000000000847

Ejemplares similares

SAT-032 Follistatin-Like 3 (FSTL3) and Early Postnatal Testicular Development
por: Mejia, Randy Ballesteros, et al.
Publicado: (2020)

A role for Follistatin-like protein 1 (FSTL1) in colorectal cancer
por: Voutsadakis, Ioannis A.
Publicado: (2020)

The BMP inhibitor follistatin-like 1 (FSTL1) suppresses cervical carcinogenesis
por: Zhao, Chenjing, et al.
Publicado: (2023)

Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer
por: Li, Li, et al.
Publicado: (2020)

Expression and functional analysis of the Follistatin‐like 3 (FSTL3) gene in the sheep ovary during the oestrous cycle
por: He, Jianning, et al.
Publicado: (2020)

Identifying pathogenic variants in the Follistatin‐like 1 gene (FSTL1) in patients with skeletal and atrioventricular valve disorders
por: Prakash, Stuti, et al.
Publicado: (2019)

Follistatin like-1 (Fstl1) is required for the normal formation of lung airway and vascular smooth muscle at birth
por: Liu, Xue, et al.
Publicado: (2017)

Follistatin-Like-1 (FSTL1) Is a Fibroblast-Derived Growth Factor That Contributes to Progression of Chronic Kidney Disease
por: Maksimowski, Nicholas A., et al.
Publicado: (2021)

Follistatin‐like protein 1 (FSTL1) promotes chondrocyte expression of matrix metalloproteinase and inflammatory factors via the NF‐κB pathway
por: Hu, Peng‐Fei, et al.
Publicado: (2019)

Follistatin like protein (FSTL-1) levels are elevated in acute Kawasaki Disease and may differentiate between patients with and without aneurysm formation
por: Gorelik, Mark, et al.
Publicado: (2012)

Follistatin-like 1 (FSTL1) interacts with Wnt ligands and Frizzled receptors to enhance Wnt/β-catenin signaling in obstructed kidneys in vivo
por: Zhang, Yu, et al.
Publicado: (2022)

Follistatin‐like protein 5 inhibits hepatocellular carcinoma progression by inducing caspase‐dependent apoptosis and regulating Bcl‐2 family proteins
por: Li, Chunlei, et al.
Publicado: (2018)

SUN-552 Follistatin-Like 3 (FSTL3), a Transforming Growth Factor β (TGFβ) Ligand Inhibitor, Regulates Placental Development in Mice
por: Huntington, Josef, et al.
Publicado: (2020)

LGR5 promotes hepatocellular carcinoma metastasis through inducting epithelial-mesenchymal transition
por: Liu, Jie, et al.
Publicado: (2017)

USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma
por: Meng, Jing, et al.
Publicado: (2019)

Tspan5 promotes epithelial–mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling
por: Xie, Qian, et al.
Publicado: (2021)

FZD5 prevents epithelial-mesenchymal transition in gastric cancer
por: Dong, Dan, et al.
Publicado: (2021)

Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
por: Deng, Yan-Ru, et al.
Publicado: (2016)

IGF-1 induces the epithelial-mesenchymal transition via Stat5 in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2017)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

Protopanaxadiol inhibits epithelial–mesenchymal transition of hepatocellular carcinoma by targeting STAT3 pathway
por: Yang, Lan, et al.
Publicado: (2019)

ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition
por: Ye, Zhiyu, et al.
Publicado: (2018)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

Integrin α5/ITGA5 Promotes The Proliferation, Migration, Invasion And Progression Of Oral Squamous Carcinoma By Epithelial–Mesenchymal Transition
por: Deng, Yun, et al.
Publicado: (2019)

NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells
por: Hu, Bo, et al.
Publicado: (2018)

The Correlation between FSTL1 Expression and Airway Remodeling in Asthmatics
por: Liu, Yahui, et al.
Publicado: (2017)

Corylin Suppresses Hepatocellular Carcinoma Progression via the Inhibition of Epithelial-Mesenchymal Transition, Mediated by Long Noncoding RNA GAS5
por: Chen, Chi-Yuan, et al.
Publicado: (2018)

JPHYD Inhibits miR-21-5p/Smad7-Mediated Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells
por: Liu, Li-Hua, et al.
Publicado: (2022)

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?
por: Kaplan, Huseyin, et al.
Publicado: (2023)

Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
por: Dong, Qiongzhu, et al.
Publicado: (2016)

HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
por: Lv, Xiupeng, et al.
Publicado: (2015)

SCARA5 inhibits gastric cancer progression via epithelial-mesenchymal transition suppression
por: Zhang, Hangyu, et al.
Publicado: (2021)

Fatty acid‐binding protein 5 function in hepatocellular carcinoma through induction of epithelial–mesenchymal transition
por: Ohata, Takanori, et al.
Publicado: (2017)

Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5
por: Xu, Rongzhong, et al.
Publicado: (2021)

Follistatin-like 1 in development and human diseases
por: Mattiotti, Andrea, et al.
Publicado: (2018)

SUN-218 The Role Of Fstl3 In Spermatogenesis: A Transcriptome Analysis
por: Ballesteros, Randy, et al.
Publicado: (2019)

microRNA-145-5p inhibits prostate cancer bone metastatic by modulating the epithelial-mesenchymal transition
por: Luo, Bingfeng, et al.
Publicado: (2022)

The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target
por: Qin, Cheng-Dong, et al.
Publicado: (2018)

Collagen XV mediated the epithelial-mesenchymal transition to inhibit hepatocellular carcinoma metastasis
por: Yao, Ting, et al.
Publicado: (2022)

Matrine inhibits the invasive and migratory properties of human hepatocellular carcinoma by regulating epithelial-mesenchymal transition
por: Wang, Yuwen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dg00c3131eib56esf6u6ivicon